151 related articles for article (PubMed ID: 19719941)
1. Integrated assessment of potential value of erbB-2 amplification or expression status as novel therapy target in Chinese children and adolescents with osteosarcoma.
Shang J; Bi ZG; Ji HF; Wang WB
Chin Med J (Engl); 2009 Jul; 122(13):1521-4. PubMed ID: 19719941
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomas.
Anninga JK; van de Vijver MJ; Cleton-Jansen AM; Kristel PM; Taminiau AH; Nooij M; Egeler RM; Hogendoorn PC
Eur J Cancer; 2004 May; 40(7):963-70. PubMed ID: 15093570
[TBL] [Abstract][Full Text] [Related]
3. HER2 amplification and overexpression is not present in pediatric osteosarcoma: a tissue microarray study.
Somers GR; Ho M; Zielenska M; Squire JA; Thorner PS
Pediatr Dev Pathol; 2005; 8(5):525-32. PubMed ID: 16211448
[TBL] [Abstract][Full Text] [Related]
4. ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma.
Onda M; Matsuda S; Higaki S; Iijima T; Fukushima J; Yokokura A; Kojima T; Horiuchi H; Kurokawa T; Yamamoto T
Cancer; 1996 Jan; 77(1):71-8. PubMed ID: 8630943
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of HER2/neu expression by real-time PCR and fluorescent in situ hybridization analysis in low-grade osteosarcoma.
Lee WI; Bacchni P; Bertoni F; Maeng YH; Park YK
Oncol Rep; 2004 Jul; 12(1):125-8. PubMed ID: 15201972
[TBL] [Abstract][Full Text] [Related]
6. HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancer.
Press MF; Finn RS; Cameron D; Di Leo A; Geyer CE; Villalobos IE; Santiago A; Guzman R; Gasparyan A; Ma Y; Danenberg K; Martin AM; Williams L; Oliva C; Stein S; Gagnon R; Arbushites M; Koehler MT
Clin Cancer Res; 2008 Dec; 14(23):7861-70. PubMed ID: 19047115
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of HER-2 gene status in gastric carcinoma using immunohistochemistry, fluorescence in situ hybridization, and real-time quantitative polymerase chain reaction.
Kim MA; Jung EJ; Lee HS; Lee HE; Jeon YK; Yang HK; Kim WH
Hum Pathol; 2007 Sep; 38(9):1386-93. PubMed ID: 17555797
[TBL] [Abstract][Full Text] [Related]
8. LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization.
Kresse SH; Ohnstad HO; Paulsen EB; Bjerkehagen B; Szuhai K; Serra M; Schaefer KL; Myklebost O; Meza-Zepeda LA
Genes Chromosomes Cancer; 2009 Aug; 48(8):679-93. PubMed ID: 19441093
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of the human epidermal growth factor receptor 2 oncogene is not a common feature in osteosarcoma.
Baumhoer D; Smida J; Specht K; Bink K; Quintanilla-Martinez L; Rosemann M; Siggelkow H; Nathrath WB; Atkinson MJ; Bielack S; Jundt G; Nathrath M
Hum Pathol; 2011 Jun; 42(6):859-66. PubMed ID: 21292304
[TBL] [Abstract][Full Text] [Related]
10. COPS3 amplification and clinical outcome in osteosarcoma.
Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL
Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602
[TBL] [Abstract][Full Text] [Related]
11. C-erbB-2 expression and prognostic significance in osteosarcoma.
Yalçin B; Gedikoğlu G; Kutluk T; Varan A; Akyüz C; Büyükpamukçu M
Pediatr Blood Cancer; 2008 Aug; 51(2):222-7. PubMed ID: 18421709
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Her-2/neu gene status in osteosarcoma by fluorescence in situ hybridization and multiplex and monoplex polymerase chain reactions.
Willmore-Payne C; Holden JA; Zhou H; Gupta D; Hirschowitz S; Wittwer CT; Layfield LJ
Arch Pathol Lab Med; 2006 May; 130(5):691-8. PubMed ID: 16683887
[TBL] [Abstract][Full Text] [Related]
13. Overexpression through amplification of genes in chromosome region 17p11.2 approximately p12 in high-grade osteosarcoma.
van Dartel M; Redeker S; Bras J; Kool M; Hulsebos TJ
Cancer Genet Cytogenet; 2004 Jul; 152(1):8-14. PubMed ID: 15193436
[TBL] [Abstract][Full Text] [Related]
14. HER-2/neu analysis in breast cancer bone metastases.
Zustin J; Boddin K; Tsourlakis MC; Burandt E; Mirlacher M; Jaenicke F; Izbicki J; Ruether W; Rueger JM; Bokemeyer C; Simon R; Sauter G
J Clin Pathol; 2009 Jun; 62(6):542-6. PubMed ID: 19474354
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the erbB-2 proto-oncogene in canine osteosarcoma cell lines and tumors.
Flint AF; U'Ren L; Legare ME; Withrow SJ; Dernell W; Hanneman WH
Vet Pathol; 2004 May; 41(3):291-6. PubMed ID: 15133183
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of allelic imbalance at the c-kit gene locus and c-kit overexpression by immunohistochemistry in pediatric osteosarcomas.
Entz-Werlé N; Marcellin L; Gaub MP; Guerin E; Schneider A; Berard-Marec P; Kalifa C; Brugiere L; Pacquement H; Schmitt C; Tabone MD; Jeanne-Pasquier C; Terrier P; Dijoud F; Oudet P; Lutz P; Babin-Boilletot A
J Clin Oncol; 2005 Apr; 23(10):2248-55. PubMed ID: 15800315
[TBL] [Abstract][Full Text] [Related]
17. Sporadic amplification of the MYC gene in human osteosarcomas.
Ladanyi M; Park CK; Lewis R; Jhanwar SC; Healey JH; Huvos AG
Diagn Mol Pathol; 1993 Sep; 2(3):163-7. PubMed ID: 8287230
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor in osteosarcoma: expression and mutational analysis.
Wen YH; Koeppen H; Garcia R; Chiriboga L; Tarlow BD; Peters BA; Eigenbrot C; Yee H; Steiner G; Greco MA
Hum Pathol; 2007 Aug; 38(8):1184-91. PubMed ID: 17509661
[TBL] [Abstract][Full Text] [Related]
19. ERBB-2 gene overexpression and amplification in uterine sarcomas.
Amant F; Vloeberghs V; Woestenborghs H; Debiec-Rychter M; Verbist L; Moerman P; Vergote I
Gynecol Oncol; 2004 Dec; 95(3):583-7. PubMed ID: 15581967
[TBL] [Abstract][Full Text] [Related]
20. SAS is amplified predominantly in surface osteosarcoma.
Noble-Topham SE; Burrow SR; Eppert K; Kandel RA; Meltzer PS; Bell RS; Andrulis IL
J Orthop Res; 1996 Sep; 14(5):700-5. PubMed ID: 8893761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
